Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Best Buy Co Inc (BBY) Price & Performance

AbCellera Biologics IncTrade
Best Buy Co IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Best Buy Co Inc — how do they compare? AbCellera Biologics Inc trades at $9.16 (market cap $2.99B), while Best Buy Co Inc trades at $83.25 (market cap $17.55B). The key difference: Best Buy Co Inc is far larger — about 5.9× AbCellera Biologics Inc's market cap, and Best Buy Co Inc pays a 4.61% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLBBY
Market Cap
$2.99B$17.55B
Sector
HealthConsumer Cyclical
52-Week High
$9.76$90.17
52-Week Low
$2.78$55.52
Enterprise Value
$2.58B$19.93B
Dividend Yield
4.61%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbCellera Biologics Inc

No Aura AI signal available yet.

Best Buy Co Inc

BBY trades at $82.43, up 0.52% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 39.1% ROE and trades at a P/E of 15.42, below the sector average. Recent news includes leadership changes and store format tests aimed at growth.

Outlook is mixed: analyst consensus is a hold with a $84.31 price target, but risks include declining revenue and competitive pressures. Upside potential exists if new strategies boost sales, while downside is capped by solid cash flow and dividend payments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Best Buy Co Inc

With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

Read more on BBY